More about

Renal Cell Carcinoma

News
November 12, 2021
2 min read
Save

Adjuvant therapy landscape for renal cell carcinoma continues to evolve

Adjuvant therapy landscape for renal cell carcinoma continues to evolve

For years, adjuvant therapy for renal cell carcinoma was ‘under future direction’ in any research discussion.

News
November 11, 2021
2 min read
Save

DFS after first nephrectomy predicts OS in localized renal cell carcinoma

DFS after first nephrectomy predicts OS in localized renal cell carcinoma

Post-nephrectomy recurrence appeared associated with shorter survival among patients with intermediate-high or high-risk renal cell carcinoma, according to study results presented at International Kidney Cancer Symposium.

News
November 10, 2021
3 min read
Save

COVID-19 vaccination effective for patients with renal cell carcinoma

COVID-19 vaccination effective for patients with renal cell carcinoma

Most patients with renal cell carcinoma who received commercially available COVID-19 vaccines mounted sufficient antibody response, according to study results presented at International Kidney Cancer Symposium.

News
November 09, 2021
2 min read
Save

Practice type influences oncologists’ therapy choice for metastatic renal cell carcinoma

Practice type influences oncologists’ therapy choice for metastatic renal cell carcinoma

Practice type may significantly influence providers’ choice of first-line therapy for metastatic renal cell carcinoma, according to study results presented at International Kidney Cancer Symposium.

News
November 09, 2021
3 min read
Save

Regimen ‘highly active’ among certain patients with non-clear cell renal cell carcinoma

Regimen ‘highly active’ among certain patients with non-clear cell renal cell carcinoma

The combination of cabozantinib and nivolumab showed promising efficacy for certain patients with metastatic non-clear cell renal cell carcinoma, according to phase 2 study results presented at International Kidney Cancer Symposium.

News
November 08, 2021
1 min read
Save

Radiation before immunotherapy does not affect outcomes in metastatic renal cell carcinoma

Radiation before immunotherapy does not affect outcomes in metastatic renal cell carcinoma

Radiation prior to combination immunotherapy did not influence clinical outcomes among patients with metastatic renal cell carcinoma and bone metastases, according to study results presented at International Kidney Cancer Symposium.

News
November 05, 2021
2 min read
Save

Vaccination safe for patients with renal cell carcinoma who received checkpoint inhibitors

Vaccination safe for patients with renal cell carcinoma who received checkpoint inhibitors

COVID-19 vaccination appeared safe for patients with renal cell carcinoma receiving immune checkpoint inhibitors, according to retrospective study results presented at International Kidney Cancer Symposium.

News
October 11, 2021
1 min read
Save

FDA places clinical hold on Allogene’s allogeneic CAR-T trials

FDA places clinical hold on Allogene’s allogeneic CAR-T trials

The FDA placed a clinical hold on a series of clinical trials that use Allogene Therapeutics’ AlloCAR T chimeric antigen receptor T-cell therapies, according to a press release from the manufacturer.

News
September 17, 2021
3 min read
Save

Nivolumab-ipilimumab combination confers durable benefit in advanced renal cell carcinoma

Nivolumab-ipilimumab combination confers durable benefit in advanced renal cell carcinoma

First-line nivolumab plus ipilimumab conferred durable survival benefit compared with sunitinib for patients with advanced renal cell carcinoma, according to results of the randomized phase 3 CheckMate-214 trial.

News
August 12, 2021
2 min read
Save

FDA approves Keytruda-Lenvima combination for advanced renal cell carcinoma

FDA approves Keytruda-Lenvima combination for advanced renal cell carcinoma

The FDA approved the combination of pembrolizumab and lenvatinib for first-line treatment of adults with advanced renal cell carcinoma.

View more